Title : The Prognostic Value of Whole-Blood PSMB5, CXCR4, POMP, and RPL5 mRNA Expression in Patients with Multiple Myeloma Treated with Bortezomib.

Pub. Date : 2021 Feb 25

PMID : 33668794






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The aim of our study is to assess the expression of previously described genes that may influence the resistance to bortezomib treatment at the mRNA level (ABCB1, CXCR4, MAF, MARCKS, POMP, PSMB5, RPL5, TXN, and XBP1) and prognosis of MM patients. Bortezomib ATP binding cassette subfamily B member 1 Homo sapiens